Location History:
- Mölndal, SE (2008 - 2024)
- Göthenburg, SE (2024)
Company Filing History:
Years Active: 2008-2025
Title: Anna Ingrid Kristina Berggren: Innovator in Pharmaceutical Chemistry
Introduction
Anna Ingrid Kristina Berggren is a prominent inventor based in Mölndal, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various diseases. With a total of 5 patents to her name, her work has the potential to impact the treatment of respiratory diseases, cancer, and autoimmune disorders.
Latest Patents
Among her latest patents is a groundbreaking application titled "Substituted indazoles as IRAK4 inhibitors." This patent relates to chemical compounds that inhibit IRAK4 and can be utilized in treating respiratory diseases, cancer, inflammatory diseases, and autoimmune conditions. Another notable patent is for "JAK1 selective inhibitors," which discloses compounds that have specific pharmaceutical applications. These innovations highlight her commitment to advancing medical science through her research.
Career Highlights
Throughout her career, Anna has worked with AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca has allowed her to contribute to significant advancements in drug development and therapeutic solutions. Her expertise in pharmaceutical chemistry has positioned her as a key player in her field.
Collaborations
Anna has collaborated with notable professionals in her industry, including Karl Magnus Nilsson and Johan R Johansson. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Anna Ingrid Kristina Berggren is a distinguished inventor whose work in pharmaceutical chemistry continues to pave the way for new treatments. Her patents and collaborations reflect her dedication to improving healthcare through innovative solutions.